Browse
Submit Data
Databases
API
Help

Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Flutamide treated rat hepatocytes in microfluidic biochips

ABSTRACT: We investigated the effects of the flutamide (FLU) -induced liver injury in primary rat hepatocytes using our liver microfluidic biochips. Flutamide is used a non-steroidal anti-androgenic drug. Two flutamide concentrations, 10M-BM-5M and 100M-BM-5M, were used to expose the hepatocytes for 24h under perfusion. Primary rat hepatocytes were cultivated in microfluidic biochips and treated with 10 and 100M-BM-5M of flutamide for 24h

ORGANISM(S): Rattus norvegicus

SUBMITTER: Florent Dumont

PROVIDER: E-GEOD-44317 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

Flutamide treated rat hepatocytes in microfluidic biochips

Project description:We investigated the effects of the flutamide (FLU) -induced liver injury in primary rat hepatocytes using our liver microfluidic biochips. Flutamide is used a non-steroidal anti-androgenic drug. Two flutamide concentrations, 10µM and 100µM, were used to expose the hepatocytes for 24h under perfusion.

2013-12-01 | GSE44317 | GEO

Rattus norvegicus

Project description:Flutamide treated rat hepatocytes in microfluidic biochips

| PRJNA189450 | ENA

Expression Profiles of HepG2 cells treated with following oxidants: 100M-BM-5M menadione, 200M-BM-5M TBH or 50M-BM-5M H2O2

Project description:The transcriptomic changes induced in the human liver cell line HepG2 by 100M-BM-5M menadione, 200M-BM-5M TBH or 50M-BM-5M H2O2 after treatment for 0.5, 1, 2, 4, 6, 8 and 24h. The study investigated differential gene expression in HepG2 cell line mRNA following 0.5, 1, 2, 4, 6, 8 and 24h hours of exposure to 100M-BM-5M menadione, 200M-BM-5M TBH or 50M-BM-5M H2O2 and medium without compound. Three biological replicates per compound/solvent. In total 126 arrays.

2013-05-31 | E-GEOD-39291 | biostudies-arrayexpress

Whole genome analysis regulation in HepG2 cells exposed to cadmium

Project description:Cadmium (Cd) is a metal present in working and living environments known to be toxic and carcinogenic, but its mechanism of action remains still unclear. We investigated the gene expression modulation in human hepatoma cell line HepG2 after exposure to 2 M-BM-5m and 10 M-BM-5m cadmium using Agilent Whole human genome expression microarray. HepG2 cells were treated for 24 hours with 2 M-NM-<M and 10 M-NM-<M Cd and normal medium as control. Three independent replicates were used for the each type of stimuli.

2012-04-30 | E-GEOD-31286 | biostudies-arrayexpress

Transcription profiling of Mitotane induced expression changes in adrenocortical carcinoma cell-line NCI-H295

Project description:Human ACC cell-line NCI-H295 was treated in biological triplicate for 6 hours with 50M-eM-5M (16 mg/l) and 100M-eM-5M (32 mg/l) mitotane or diluent as control.Genome-wide gene expression analyses were performed using the Affymetrix HG_133_plus2 array to identify the molecular mechanisms underlying mitotane action in an unsupervised fashion.

2015-09-01 | E-MTAB-3241 | biostudies-arrayexpress

Expression Profiles of PMH treated with 7M-BM-5M of the genotoxic compound cisplatin

Project description:The transcriptomic changes induced in primary mouse hepatocytes (C57BL/6 ) by 7M-BM-5M of cisplatin after treatment for 24 and 48h The study investigated differential gene expression in PMH mRNA following 24 and 48 hours of exposure to 7M-BM-5M of cisplatin and its solvent. Three biological replicates per compound/solvent. In total 12 arrays.

2013-12-05 | E-GEOD-38123 | biostudies-arrayexpress

Yy1 occupancy of mouse ES cell genome

Project description:These data include the genome wide location analyses of Yy1 by bioChIPs of Fbio-Yy1.

2012-01-04 | GSE31785 | GEO

Alexandrium_copepod_interaction_II

Project description:A. tamarense strains were incubated in 500mL glass bottles at a concentration of approximately 5M-W106 cells L?1 in K/10 medium. Grazed treatments received 10 Centropages typicus individuals per bottle.

2011-11-28 | E-MEXP-3422 | biostudies-arrayexpress

Pathochip of Streptococcus spp surface proteins

Project description:In order to appreciate the presence of surface protein gene homologues in commensal species S. mitis and S. oralis, comparative genomic hybridization studies using DNA microarrays were performed with 8 S. mitis and 11 S. oralis from different geographic locations. The oligonucleotide microarray was designed based on the genomes of S. pneumoniae R6 and TIGR4 as well as S. mitis B6 to include genes of 63 cell surface proteins. The denatured genomic DNA of the S. mitis and S. oralis strains was labeled with Cy3-dCTP and control S. mitis B6 DNA was labeled with Cy5-dCTP. Hybridization was performed following the manufacturers recommendations using an hybridization temperature of 40C for 16 h. For data processing, microarrays were scanned on the laser scanner Pro Scan Array GX (PerkinElmer) with the low resolution of 50 M-5m using ScanArrayExpress Software version 4.0. Photomultiplier tube was adjusted to balance the two fluorescence channels and biochips were scanned with a resolution of 10 M-5m. After elimination of background values fluorescence intensity was determined. Signals that showed an intensity ratio of 0.3 and above were considered to be positive.

2011-09-15 | E-MEXP-3360 | biostudies-arrayexpress

Antiandrogen Flutamide-Induced Restoration of miR-449 Expression Mitigates Molecular Markers Associated with Ovarian Cancer Risk

Project description:The involvement of the androgen receptor (AR) pathway in the development of epithelial ovarian cancer is increasingly recognized. We examined the effects of the anti-androgen agent flutamide on miRNA expression in women at high risk (HR) for ovarian cancer. Flutamide treatment restored the reduced expression of miR-449a and miR-449b-5p in HR tissues, thereby decreasing CSF1R and AR expression associated with an increased risk of ovarian cancer. In addition to the known direct binding of flutamide to the AR, we found that flutamide also suppresses AR expression via miR-449a and miR-449b-5p upregulation, revealing a novel dual-inhibitory mechanism on the AR pathway. Taken together, our study highlights the chemopreventive potential of flutamide in ovarian cancer and suggests avenues for future research and clinical applications.

2024-12-18 | GSE252170 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data